Sonoma Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The …

Drug Manufacturers - Specialty & Generic
US, Woodstock [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Sonoma Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Sonoma Pharmaceuticals, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Sonoma Pharmaceuticals, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of SNOA's Analysis
CIK: 1367083 CUSIP: 83558L204 ISIN: US83558L2043 LEI: - UEI: -
Secondary Listings
SNOA has no secondary listings inside our databases.